{"version":"1.0","type":"link","title":"Cell-cycle targeted cancer therapy: clinical advances, biological gaps, and the emergence of selective CDK4 inhibitors.","author_name":"Safaroghli-Azar A 외","author_url":"https://prs-insight.online/author/Safaroghli-Azar%20A","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/77402","thumbnail_width":1200,"thumbnail_height":630}